Business Description
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Business History
Price Overview
Last updated: Jun 27, 2026 11:04am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -0.43
Total Equity: $41.01M
Shares: 94,204,138
Total Debt: $0.00
Cash: $35.09M
EBITDA: -$33.37M
Total Debt: $0.00
Cash: $35.09M
Revenue: $13.56M
Shares: 94,204,138
Revenue: $13.56M
Revenue: $13.56M
Revenue: $13.56M
Total Equity: $41.01M
Tax Rate: 0.0%
Equity: $41.01M
Total Debt: $0.00
Cash: $35.09M
Current Liabilities: $11.73M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $41.01M
Shares: 94,204,138
Shares: 94,204,138
CapEx: -$1.19M
Shares: 94,204,138
Stock Price: $1.47
Net Income: -$35.57M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 26, 2026 1:21am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.5M | $6.8M | $11.0M | $12.9M | $13.6M |
| Cost of Revenue | $2.7M | $5.9M | $6.3M | $7.0M | $6.8M |
| Gross Profit | -$1.2M | $907,000 | $4.8M | $5.9M | $6.8M |
| Operating Expenses | $63.7M | $74.8M | $52.9M | $49.1M | $43.8M |
| Operating Income | -$64.9M | -$73.9M | -$48.1M | -$43.2M | -$37.1M |
| Net Income | -$64.8M | -$73.2M | -$44.2M | -$40.7M | -$35.6M |
| EBITDA | -$64.1M | -$72.1M | -$43.2M | -$39.7M | -$33.4M |
| EPS | $-0.92 | $-1.04 | $-0.62 | $-0.56 | $-0.43 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 26, 2026 1:21am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $188.5M | $118.2M | $75.2M | $37.6M | $35.1M |
| Total Current Assets | $197.5M | $128.7M | $88.9M | $53.7M | $50.9M |
| Total Assets | $202.5M | $134.1M | $94.2M | $58.9M | $55.3M |
| Current Liabilities | $15.7M | $8.8M | $8.8M | $8.7M | $11.7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $16.2M | $10.3M | $9.8M | $9.9M | $14.3M |
| Total Equity | $186.2M | $123.7M | $84.4M | $49.0M | $41.0M |
| Retained Earnings | -$136.3M | -$209.5M | -$253.7M | -$294.4M | -$330.0M |
Cash Flow (Annual)
Last updated: Jun 26, 2026 1:21am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.2M | -$72.3M | -$41.8M | -$38.8M | -$27.9M |
| Capital Expenditure | -$2.7M | $-585,000 | $-804,000 | $-383,000 | -$1.2M |
| Free Cash Flow | -$49.9M | -$72.9M | -$42.6M | -$39.2M | -$29.1M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $126.9M | -$72.9M | -$42.4M | -$38.1M | -$1.6M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 11:04am (just now)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$20.2M $20.0M – $20.3M
|
$26.3M $26.0M – $26.6M
|
$34.9M $34.9M – $34.9M
|
$29.4M $29.2M – $29.7M
|
| EBITDA |
-$20.2M -$20.3M – -$20.0M
|
-$26.3M -$26.6M – -$26.0M
|
-$34.9M -$34.9M – -$34.9M
|
-$29.4M -$29.7M – -$29.2M
|
| Net Income |
-$32.7M -$33.1M – -$32.4M
|
-$31.6M -$31.9M – -$31.3M
|
-$29.2M -$29.6M – -$28.9M
|
-$27.3M -$27.7M – -$27.1M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 26, 2026 1:21am (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +355.5% | +61.9% | +16.8% | +5.2% |
| Gross Profit Growth | +177.7% | +424.5% | +23.8% | +14.6% |
| Operating Income Growth | -13.9% | +34.9% | +10.2% | +14.2% |
| Net Income Growth | -12.8% | +39.5% | +8.0% | +12.6% |
| EBITDA Growth | -12.5% | +40.1% | +8.0% | +16.0% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Wolterman Dan | A-Award | 52,600.00 | $1.49 | $78,374 |
| 2026-05-26 | HALE BRETT | S-Sale | 6,047.00 | $1.65 | $9,978 |
| 2026-05-26 | TEISSEYRE THOMAS | S-Sale | 6,047.00 | $1.65 | $9,978 |
| 2026-05-22 | Fattori Ruth A | A-Award | 157,700.00 | $1.49 | $234,973 |
| 2026-05-22 | Wolterman Dan | A-Award | 157,700.00 | $1.49 | $234,973 |
| 2026-05-22 | Dahldorf John T | A-Award | 157,700.00 | $1.49 | $234,973 |
| 2026-05-22 | ROTHBERG JONATHAN M | A-Award | 157,700.00 | $1.49 | $234,973 |
| 2026-03-31 | HALE BRETT | A-Award | 330,000.00 | $0.00 | $0 |
| 2026-03-31 | TEISSEYRE THOMAS | A-Award | 330,000.00 | $0.00 | $0 |
| 2026-03-31 | Sainz Maria | A-Award | 750,000.00 | $0.00 | $0 |
| 2026-03-23 | TEISSEYRE THOMAS | S-Sale | 24,188.00 | $1.21 | $29,267 |
| 2026-03-23 | HALE BRETT | S-Sale | 24,188.00 | $1.21 | $29,267 |
| 2026-02-13 | TEISSEYRE THOMAS | S-Sale | 821.00 | $1.11 | $913 |
| 2025-11-19 | TEISSEYRE THOMAS | S-Sale | 1,405.00 | $1.08 | $1,517 |
| 2025-08-18 | TEISSEYRE THOMAS | S-Sale | 1,151.00 | $1.33 | $1,531 |
| 2025-06-05 | Wolterman Dan | A-Award | 81,817.00 | $0.86 | $70,649 |
| 2025-03-31 | HALE BRETT | A-Award | 300,000.00 | $0.00 | $0 |
| 2025-03-31 | TEISSEYRE THOMAS | A-Award | 300,000.00 | $0.00 | $0 |
| 2025-05-20 | Fattori Ruth A | A-Award | 79,200.00 | $0.62 | $49,286 |
| 2025-05-20 | Wolterman Dan | A-Award | 79,200.00 | $0.62 | $49,286 |
Narrative Economics
market-narrative step).